Corcept must face Teva’s US antitrust claims over Korlym, judge rules
MLex Summary: Teva Pharmaceuticals has sufficiently alleged an exclusive agreement and substantial market foreclosure by Corcept regarding branded Korlym, a US judge ruled. District Judge Noël Wise denied a motion to...To view the full article, register now.
Already a subscriber? Click here to view full article